Cipla's protein-bound paclitaxel is a generic therapeutic equivalent version of Bristol Myers Squibb's Abraxane for injectable suspension 100 mg/vial.

Cipla has launched an innovative combination of 3 HIV/AIDS drugs, Viraday that needs to be taken just once a day for effective treatment. Cipla has launched an innovative combination of 3 HIV/AIDS ...

Nomura India has reaffirmed its 'Buy' rating on Cipla Ltd with a target price of Rs 1,780 by March 2026. This valuation is based on 28.5 times Cipla's projected earnings per share of Rs 62.30 for ...